Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: Incidence, causes, and outcome

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 385-393

  Schwartz, Jonathan M ^b   Wolford, John L ^a,b   Thornquist, Mark D ^a   Hockenbery, David M ^a,b   Murakami, Carol S ^a,b   Drennan, Fred ^a,b   Hinds, Mary ^a   Strasser, Simone I ^a,b   Lopez Cubero, Santiago Otero ^a   Brar, Harpreet S ^b   Ko, Cynthia W ^b   Saunders, Michael D ^b   Okolo, Charles N ^b   McDonald, George B ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DEMOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFANT; INTESTINE ULCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; VIRUS INFECTION;

ADULT; BLOOD TRANSFUSION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035129815     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02342-X     Document Type: Article

References (61)

1. The national ASGE survey on upper gastrointestinal bleeding. III. Endoscopy in upper gastrointestinal bleeding
2. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom
3. Approach to the patient with acute upper gastrointestinal hemorrhage
4. Endoscopic therapy for severe gastrointestinal bleeding
5. The diagnostic accuracy of the rectal biopsy in graft-versus-host disease: A prospective study of thirteen patients
6. Regimen-related toxicity in patients undergoing bone marrow transplantation
7. Modification of regimen-related cellular toxicity
8. Diffuse intestinal ulceration after marrow transplantation: A clinical-pathological study of 13 patients
9. The human gastrointestinal tract after allogenic marrow transplantation
10. Endoscopic and histologic diagnosis of intestinal graft-vs.-host disease after marrow transplantation
11. Gastrointestinal, and hepatic complications
12. Graft-versus-host disease
13. Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
14. Phase I study of high dose busulfan, melphalan, and thiotepa with autologous stem cell support in patients with refractory malignancies
15. Phase II study of high-dose busulfan, melphalan, and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease
16. Laminar air flow isolation and decontamination: A prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients
17. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study
18. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of CMV disease in allogeneic marrow transplant recipients
19. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - A prospective, randomized, double-blind study
20. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: An autopsy study of 355 patients
21. Effects of acid suppression on microbial flora of upper gut
22. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole
23. Review article: Infective complications of therapeutic gastric acid inhibition
24. Incidence of infectious complications associated with the use of histamine-2-receptor antagonists in critically ill patients
25. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS
26. Cimetidine and granulopoiesis: Bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia
27. Pharmocodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFUs)
28. The use of ranitidine in bone marrow transplantation
29. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies
30. Persistent nausea and anorexia after marrow transplantation: A prospective study of 78 patients
31. Acute upper gastrointestinal graft-versus-host disease: Clinical significance and response to immunosuppressive therapy
32. Acute graftversus-host disease of the esophagus
33. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graftversus-host disease
34. A histopathologic study of gastric and small intestine graft-versus-host disease following allogeneic bone marrow transplantation
35. Gastric graftversus-host disease: A blinded histologic study
36. Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods
37. Esophageal infections in immunosuppressed patients after marrow transplantation
38. Esophageal infections: Risk factors, presentation, diagnosis, and treatment
39. An evaluation of 99Tc-labeled red blood cell scintigraphy for the detection and localization of gastrointestinal bleeding sites
40. Bleeding from gastric antral vascular ectasia in marrow transplant patients
41. Gastric vascular ectasia in patients undergoing bone marrow transplantation
42. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
43. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with TBI-containing regimens
44. Gancyclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant
45. Gancyclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double blind trial
46. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient
47. Pharmacology and use of immunosuppressive agents after hematopoietic cell transplantation
48. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL
49. Acute bleeding after bone marrow transplantation (BMT)-incidence and effect on survival. A quantitative analysis in 1402 patients
50. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines
51. A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment
52. Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation
53. Graft-v-host disease is associated with autoimmune-like thrombocytopenia
54. A multicenter study of platelet recovery and utilization in patients after myeloblative therapy and hematopoietic stem cell transplantation
55. The problem of thrombocytopenia after hematopoietic stem cell transplantation
56. Isolated thrombocytopenia after allogeneic bone marrow transplantation: Existence of transient and chronic thrombocytopenic syndromes
57. Delay in platelet recovery after bone marrow transplantation: Impact of cytomegalovirus infection
58. A prospective study of unexplained nausea and vomiting after marrow transplantation
59. Intramural hematomas of esophagus, stomach and small intestine in marrow transplant patients
60. Etiology and outcome of diarrhea after marrow transplantation: A prospective study
61. Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients